FIBRONECTINBINDENDE PEPTIDE ZUR VERWENDUNG BEI DER DIAGNOSE EINES TUMORS ODER VON FIBROSE UND THERAPIE
European patent · EP4282490 · In force
Register entry
- Publication number
- EP4282490
- Application number
- EP23197928
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 14, 2017
- Published
- Nov 29, 2023
- Granted
- Nov 12, 2025
- Protection ends at the latest
- Jun 13, 2037
- Next annual fee due
- Jun 30, 2027
- IPC classes
- C07K 14/435 (2006.01)C07K 14/78 (2006.01)A61P 1/16 (2006.01)A61P 3/10 (2006.01)A61P 9/10 (2006.01)A61P 11/00 (2006.01)A61P 13/12 (2006.01)A61P 19/02 (2006.01)A61P 29/00 (2006.01)A61P 35/00 (2006.01)A61P 35/02 (2006.01)A61P 37/02 (2006.01)A61P 37/06 (2006.01)A61P 43/00 (2006.01)
- Priority
- EP 16174824 16.06.2016
- Divided from
- EP17731525
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 23, 2026
Change
Published in Swissreg on 23.09.2026
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Mar 4, 2026
Agent entered
- Representative
- Vossius & Partner, Patentanwälte Rechtsanwälte mbB, Hirschgässlein 11, 4051 Basel
Published in Swissreg on 04.03.2026
- Nov 12, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 12.11.2025
Parties
Inventor
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.